USPTO 2015–2025 USPTO PatentsView US Corporation

Cellepathy Inc.

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04W (Wireless Communication Networks).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cellepathy ranks #24,074 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#24,074
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.9/100)
22.2
avg claims per patent
-78%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24074 · US Corporation #24,074 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,074/49,997
  • PHOTO-FINISH Carpenter Technology
  • CPC-NARROW H04W · 8 areas
  • INNOV-THIN 31.9/100
  • CLAIMS-DENSE 22.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -78% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carpenter Technology Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cellepathy’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cellepathy

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cellepathy's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cellepathy?

Each dot is one of Cellepathy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cellepathy’s own 22.2 claims/patent is ABOVE the 16.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cellepathy vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 12141618202224 Granted patents (volume) Avg claims / patent Carpenter Technology Corporation - 11, 13.18Carpenter Technol…Casetext, Inc. - 11, 19.09CasetextCatalytic Combustion Corporation - 11, 19Catalytic Combust…Ceelox Patents, LLC - 11, 17.91Ceelox PatentsCellview Imaging Inc. - 11, 15.55Cellview ImagingCentera Photonics Inc. - 11, 13.27Centera PhotonicsCeramic Data Solutions GmbH - 11, 19.45Ceramic Data Solu…CertainTeed Canada, Inc. - 11, 16.73Certainteed CanadaCellepathy Inc. - 11, 22.18Cellepathy
Cellepathy vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cellepathy's grants concentrate

Cellepathy Inc. is a focused PatentsView assignee: 8 CPC subclasses with 72.7% of grants classified under H04W (Wireless Communication Networks). Peak complete grant year is 2017 (4 grants) versus a trough of 2 in 2015. By volume, Cellepathy sits between Carpenter Technology Corporation and CertainTeed Canada, Inc..

Who files at Cellepathy's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cellepathy holds 11 patents at rank #24,122, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cellepathy

By rank, the assignees closest to #24,122 in granted patent volume.

Leaders in H04W (Wireless Communication Networks)

Other assignees with the most granted patents in Cellepathy's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cellepathy, neither rank-band nor same-CPC leaders (those blocks stay above). In H04W (Wireless Communication Networks), Cellepathy ranks #1,588 of 5,904 assignees by patent count in that subclass.

Cellepathy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.544.5 2015201720182021 2
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cellepathy Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 18.2%
2017 4 36.4%
2018 3 27.3%
2021 2 18.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cellepathy Inc.'s patent record in context - here's where to go next.

  • Cellepathy Inc.'s lead technology class is H04W (Wireless Communication Networks), 72.7% of its portfolio - see every assignee active in that class. Explore H04W
  • Ranked #24,074 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cellepathy Inc. against Carpenter Technology Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.